Genenta Science S.p.A. (SAEN)
NASDAQ: SAEN · Real-Time Price · USD
0.6240
-0.0560 (-8.24%)
At close: Nov 12, 2026, 4:00 PM EST
0.6241
+0.0001 (0.02%)
Pre-market: Nov 13, 2026, 4:01 AM EST
Genenta Science Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
| 30 | 35 | 58 | 56 | 73 | 80 | 78 | 57 | 64 | 90 | 94 | |
Market Cap Growth (YoY) | -41.64% | -56.12% | -25.53% | -1.77% | 13.88% | -11.77% | -16.75% | -47.20% | -39.13% | - | - |
Enterprise Value | 6 | 23 | 45 | 43 | 60 | 61 | 57 | 36 | 43 | 66 | 62 |
Last Close Price | 0.62 | 1.49 | 3.18 | 3.04 | 3.97 | 4.35 | 4.27 | 3.10 | 3.50 | 4.95 | 5.15 |
Price Ratios
Fiscal Quarter | Current | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
PB Ratio | 0.57 | 1.36 | 2.27 | 3.92 | 5.55 | 6.15 | 5.60 | 3.15 | 3.51 | 3.99 | 4.34 |
P/TBV Ratio | 1.17 | 1.36 | 2.27 | 3.92 | 5.55 | 6.15 | 5.60 | 3.15 | 3.51 | 3.99 | 4.34 |
Financial Efficiency
Fiscal Quarter | Current | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
Debt / Equity Ratio | 0.35 | 0.35 | 0.35 | 0.62 | 0.62 | - | - | 0.00 | 0.00 | - | - |
Net Debt / Equity Ratio | -0.94 | -0.94 | -0.94 | -0.83 | -0.83 | -1.01 | -1.01 | -1.00 | -1.00 | -0.92 | -0.92 |
Net Debt / EBITDA Ratio | 3.13 | 3.13 | 2.71 | 1.18 | 1.11 | 1.30 | 1.32 | 1.80 | 1.60 | 1.61 | 1.48 |
Net Debt / FCF Ratio | 2.99 | 2.99 | 2.48 | 1.04 | 1.27 | 2.03 | 2.12 | 2.97 | 2.00 | 1.67 | 1.59 |
Quick Ratio | 13.90 | 13.90 | 13.90 | 12.64 | 12.64 | 6.72 | 6.72 | 9.07 | 9.07 | 11.97 | 11.97 |
Current Ratio | 14.16 | 14.16 | 14.16 | 13.20 | 13.20 | 6.89 | 6.89 | 9.30 | 9.30 | 12.25 | 12.25 |
Return on Equity (ROE) | -38.03% | -38.03% | -44.36% | -60.15% | -60.88% | -54.13% | -54.17% | -42.89% | -49.42% | -45.16% | -48.03% |
Return on Assets (ROA) | -17.67% | -17.67% | -20.38% | -26.59% | -28.34% | -32.84% | -32.31% | -25.83% | -28.94% | -26.29% | -28.48% |
Return on Capital Employed (ROCE) | -22.20% | -22.20% | -25.60% | -43.20% | -46.10% | -76.70% | -75.50% | -55.50% | -62.20% | -56.90% | -61.70% |
Yields
Fiscal Quarter | Current | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
Earnings Yield | -62.34% | -21.96% | -15.36% | -18.35% | -13.11% | -11.60% | -12.74% | -16.87% | -17.40% | -14.27% | -13.97% |
FCF Yield | -25.26% | -23.12% | -16.73% | -20.47% | -11.87% | -8.13% | -8.52% | -10.75% | -14.30% | -13.75% | -13.36% |
Buyback Yield / Dilution | -7.86% | -7.86% | -4.74% | -1.60% | -0.96% | -0.31% | -0.21% | -0.11% | -0.06% | 0.00% | -4.03% |